Disruptions in liver function among cancer patients and patients treated with tyrosine kinase inhibiting drugs: Comparisons of two population-based databases

• Main Authors: Landis, S.H, Nordstrom, B.L, Sansbury, L.B, Shantakumar, S, Laurent, S.A.S, Fraeman, K.H, Nelson, J.J
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2020
• Subjects: dasatinib; erlotinib; gefitinib; imatinib; lapatinib; nilotinib; adult; article; cancer patient; drug exposure; electronic medical record; female; health insurance; human; liver dysfunction; major clinical study; male; priority journal
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181816
• Institution: National University of Singapore

10.1155/2013/358285